Validation of the French version of the Fecal Incontinence Quality-of-Life (FIQL) scale

Rullier, Éric; Zerbib, Frank; Marrel, Alexia; Amouretti, M; Lehur, Paul‐Antoine

doi:10.1016/s0399-8320(04)95012-9

Cited by 100 publications

(87 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In this study of the impact on QOL of FI in rural and regional north Queensland, our overall FIQL results for lifestyle (3.24), coping (2.23), depression (2.42) and embarrassment (2.33) were within the range of comparable clinic-based studies in other countries [21,[27][28][29][30][31] , and closely reflected the scores found in a similar study conducted at a Pelvic Floor Center in Minnesota, USA [21] and baseline scores from two Victorian (Australia) clinical studies that investigated injectable material for FI [32,33] . The QOL of patients who attended the CC was more severely affected than that of participants from the UC, even though they had reported FI for a shorter duration.…”

Section: Discussionsupporting

confidence: 69%

Impact of fecal incontinence on quality of life

Bartlett¹,

Nowak²,

Ho³

2009

WJG

View full text Add to dashboard Cite

AIM:To explore the impact of fecal incontinence (FI) on quality of life (QOL) of patients attending urogynecology and colorectal clinics (CCs). METHODS:Cross-sectional study of 154 patients (27 male) with FI, who attended the clinics at a regional hospital in North Queensland, Australia in 2003 and2004, and completed the Fecal Incontinence Quality of Life Scale (FIQL: 1 = very affected; 4 = not affected). RESULTS:More than 22% of patients had their QOL affected severely by FI. Patients reported that they had not previously been asked about FI by a medical practitioner nor did they voluntarily disclose its presence. The median FIQL scores for all participants were: lifestyle = 3.24; coping = 2.23; depression = 2.42; and embarrassment = 2.33. Increasing frequency of soiling had a negative effect on all four FIQL scales (P < 0.001) as did the quantity of soiling (P < 0.01). Female CC patients had poorer FIQL scores than urogynecology clinic patients for lifestyle (P = 0.015), coping (P = 0.004) and embarrassment (P = 0.009), but not depression (P = 0.062), despite having experienced FI for a shorter period. CONCLUSION:Failure to seek treatment for FI degrades the quality of patients' lives over time. FI assessment tools should incorporate the quantity of fecal loss.

show abstract

Section: Discussionsupporting

confidence: 69%

Impact of fecal incontinence on quality of life

Bartlett¹,

Nowak²,

Ho³

2009

WJG

View full text Add to dashboard Cite

show abstract

“…Secondary end points were Faecal Incontinence Quality of Life (FIQL) scores, 20 weekly number of faecal incontinence episodes, subject acceptance of treatment and adverse events at 3 months.…”

Section: Methodsmentioning

confidence: 99%

Elastomer implants in faecal incontinence: a blind, randomized placebo‐controlled study

Siproudhis¹,

Morçet

Lainé

2007

Aliment Pharmacol Ther

View full text Add to dashboard Cite

AimTo test efficacy and safety of polydimethylsiloxane elastomer implants, a silicone biomaterial, in patients with severe faecal incontinence related to an impaired internal anal sphincter. MethodsSubjects were randomized to receive three injections of 2.5 mL of either physiological saline or polydimethylsiloxane elastomer. After local anaesthesia, an 18 gauge, 2.5-in needle was inserted through the perianal skin and laid down into the intersphincteric space. Treatment (saline or polydimethylsiloxane elastomer) was administered by means of a ratchet gun. Three injections of 2.5 mL each were performed in the area of the internal anal sphincter at 3, 7 and 11 o'clock positions. Main end point was the percentage of subjects in each treatment arm experiencing a successful treatment, defined as a Cleveland Clinic FloridaFaecal Incontinence score <8, 3 months after treatment. Secondary end points were quality of life scores, weekly number of faecal incontinence episodes, subject acceptance and adverse events rate. Both patients and end point assessments were blinded to treatment.Results 44 women (64.3 AE 9 years) with a baseline Cleveland Clinic FloridaFaecal Incontinence score ‡8 were enrolled prospectively; 22 received polydimethylsiloxane elastomer and 22 saline treatment. Treatment was well tolerated. At 3 months, the percentage of subjects experiencing a successful treatment was not different between polydimethylsiloxane elastomer and saline groups (23% vs. 27%, respectively, P = 0.73). Moreover, Cleveland Clinic Florida-Faecal Incontinence score was not significantly different between polydimethylsiloxane elastomer and saline groups (11.7 AE 4.7 vs. 11.4 AE 4.5, respectively, P = 0.79). ConclusionsPolydimethylsiloxane elastomer implants cannot be recommended for treatment of severe faecal incontinence related to impaired internal anal sphincter.

show abstract

“…In addition to traditional questionnaires such as the Fecal Incontinence Questionnaire, 10 The Fecal Incontinence Severity Index, 11 Fecal Incontinence Quality of Life (FIQL), 11 Hirschsprung's Disease Anorectal Malformation QoL Questionnaire (HAQL), 5 Medical Outcomes Study 36 -Item Short -Form Health Survey, 12 and the Clinical Evaluation of Continence (Holschneider Criteria), 6 many translated versions have been created. Minguez et al validated the FIQL into Spanish, applying it to patients with fecal incontinence caused by different etiologies; 13 Rullier et al validated the FIQL into French; 14 and in Sweden, Wigander et al translated and culturally adapted the HAQL. 15 In Brazil, Yusuf et al validated the FIQL into Portuguese, but did not adapt it to children and adolescents since the mean age of their patients was 52.8 years.…”

Section: Discussionmentioning

confidence: 99%

Long-term evaluation of fecal continence and quality of life in patients operated for anorectal malformations

Tannuri

Ferreira

Mathias

et al. 2016

Rev. Assoc. Med. Bras.

View full text Add to dashboard Cite

Summary Introduction: Patients operated for correction of anorectal malformations (ARM) can develop fecal incontinence, constipation, and soiling, with loss in quality of life. Objective: To evaluate, through the use of questionnaires, fecal continence, and quality of life of children in the late postoperative follow-up of ARM correction, both high and low. In addition, the levels of fecal continence and quality of life were compared with those of a control group. Method: A Fecal Continence Index Questionnaire (ICF) and a Questionnaire for Assessment of Quality of Life Related to Fecal Continence in Children and Adolescents (QQVCFCA) were administered to 63 patients with ARM, aged from 7 to 19 years, whose surgical treatment had been completed for at least 6 months. The patients were compared to a control group of 59 children. Results: In the control group, 25 (42.4%) patients had good continence and 34 (57.6%), normal continence. We found that the quality of life in children with ARM is compromised globally, in all areas and in the ICF questionnaire, compared to controls (p<0.001). There was no difference between patients with high and low defects. Thirty-two (50.8%) patients had other associated anomalies. Conclusion: In patients operated for ARM correction, quality of life and ICF were compromised, and there was no difference between patients with high-type and low-type of the disease. In about half the cases there are other associated malformations.

show abstract

Validation of the French version of the Fecal Incontinence Quality-of-Life (FIQL) scale

Cited by 100 publications

References 16 publications

Impact of fecal incontinence on quality of life

Impact of fecal incontinence on quality of life

Elastomer implants in faecal incontinence: a blind, randomized placebo‐controlled study

Long-term evaluation of fecal continence and quality of life in patients operated for anorectal malformations

Contact Info

Product

Resources

About